Covishield, Covaxin to get full approval but won’t be retailing

The drug regulator’s subject expert committee (SEC) on Covid vaccines on Wednesday recommended full authorisation for the two widely used jabs — Covishield and Covaxin. However, the vaccines will continue to be available and administered only at the centres that are registered under the government’s CoWin platform, official sources said.

from Times of India https://ift.tt/33qTrS5